Breaking News

Financial Report: Merck 3Q11

Revenues up 8%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Merck 3Q11   3Q Revenues: $12.0 billion (+8%)   3Q Earnings: $1.7 billion (earnings were $342.0 million 3Q10)    YTD Revenues: $35.8 billion (+5%)   YTD Earnings: $4.8 billion (earnings were $1.5 billion YTD10)   Comments: Sales growth, including 5% from foreign exchange, was driven by pharmaceutical and animal health sales. Januvia sales were $846.0 million in the quarter (+41%). Gardasil sales were $445.0 million (+41%). Singulair sales were $1.3 billion (+10%). Janumet sales we...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters